uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Heterogeneity of molecular sensitization profiles in grass pollen allergy - implications for immunotherapy?
Show others and affiliations
2014 (English)In: Clinical and Experimental Allergy, ISSN 0954-7894, E-ISSN 1365-2222, Vol. 44, no 5, 778-786 p.Article in journal (Refereed) Published
Abstract [en]

BackgroundData on molecular allergy diagnostics in adults with grass pollen allergy with regard to conjunctival and nasal provocation test outcome and specific immunotherapy are lacking to date. ObjectiveTo assess whether molecular allergy diagnostics for grass pollen allergens could help with predicting provocation test outcomes and serve as a basis for future component-resolved specific immunotherapy. MethodsSera of 101 adults with grass pollen allergy was analysed for IgE against timothy grass pollen (Phleum pratense), rPhl p 1, rPhl p 2, nPhl p 4, rPhl p 5b, rPhl p 6, rPhl p 7, rPhl p 11 and rPhl p12 and correlated with the individuals' outcome in the nasal and conjunctival provocation tests and investigated in regard to a potential component-resolved specific immunotherapy. ResultsAn increasing number of sensitizations to timothy grass allergens was correlated to a positive reaction in the conjunctival (4.9 vs. 3.6, P=0.003) and nasal provocation tests (4.5 vs. 2.2, P=0.0175). In molecular sensitization profiles, a substantial heterogeneity was detected, with none of the patients exactly matching the allergen composition of a previously published component-resolved specific immunotherapy containing Phl p 1, Phl p 2, Phl p 5a/b and Phl p 6. The results indicate that in 95% of the patients, a proportion of 50% of timothy-IgE would be targeted with such a specific immunotherapy, while in 50% and 10% of patients, 80% and 90% of timothy-IgE would be targeted, respectively. Conclusion and Clinical RelevanceMolecular allergy diagnostics is a prerequisite for future component-resolved specific immunotherapy due to the high heterogeneity of sensitization profiles. However, of current clinical relevance is the observed correlation between the number of sensitizations and provocation test outcome.

Place, publisher, year, edition, pages
2014. Vol. 44, no 5, 778-786 p.
Keyword [en]
allergenic molecules, combinatorial analysis, component-resolved diagnosis, component-resolved therapy, hay fever, molecular allergy diagnostics, nasal, conjunctival provocation test, Phleum pratense, specific IgE, timothy
National Category
Immunology in the medical area
URN: urn:nbn:se:uu:diva-227738DOI: 10.1111/cea.12303ISI: 000334320600016OAI: oai:DiVA.org:uu-227738DiVA: diva2:730901
Available from: 2014-06-30 Created: 2014-06-30 Last updated: 2014-06-30Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full text

Search in DiVA

By author/editor
Borres, M. P.
By organisation
In the same journal
Clinical and Experimental Allergy
Immunology in the medical area

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 209 hits
ReferencesLink to record
Permanent link

Direct link